Author

J. H. Gunter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. C. Nelson· 2 shared A. C. Herington· 1 shared A. P. Bowman· 1 shared A. Rajapakse· 1 shared A. W. Burgess· 1 shared B. L. J. Poad· 1 shared C. Walpole· 1 shared C.-H. Lee· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. C. Nelson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivMay 30, 2023

Epidermal Growth Factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium

P. Wang, R. Zhou, R. Zhou…·E. Thompson

The paper shows EGF enhances TNBC cells' response to CAP-activated medium by activating specific EGFR phospho-tyrosines and increasing ROS levels.

DOI 10.1016/j.redox.2023.102976

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 1, 2021

Isomeric lipid signatures reveal compartmentalised fatty acid metabolism in cancer

R. S. E. Young, A. P. Bowman, K. D. Tousignant…·S. J. Blanksby

This study uses stable-isotope labelled fatty acids to reveal distinct metabolic fates of exogenous and de novo synthesized fatty acids in cancer cells, showing compartmentalized lipid metabolism.

DOI 10.1101/2021.11.01.466716

humanmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivJun 26, 2019

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype

P. B. Thomas, P. L. Jeffery, M. D. Gahete…·I. Seim

This study identifies GHSROS, a lncRNA upregulated in prostate cancer, which promotes aggressive tumor traits and may be a therapeutic target.

DOI 10.7717/peerj.10280

humanbulk RNA-seq

𝕏 PostBluesky